Clinical trial
Olanzapine in Patients With Advanced Cancer and Weight Loss
NCT00489593 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00489593 |
|---|---|
| Title | Olanzapine in Patients With Advanced Cancer and Weight Loss |
| Official title | Phase I Dose-Finding Pilot Study of the Safety and Tolerability of Olanzapine in Patients With Advanced Cancer and Weight Loss |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Cancer, Weight Loss |
| Intervention type | Drug |
| Interventions | Olanzapine |
| Enrollment | 57 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Jun 21, 2007 |
| Last update posted | Jan 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: